SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-017322
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:01
Documents
17
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61062
2 ex4-1.htm EX-4.1 177803
3 ex10-1.htm EX-10.1 204490
4 ex10-2.htm EX-10.2 178722
5 ex10-3.htm EX-10.3 147577
6 ex10-4.htm EX-10.4 21978
  Complete submission text file 0001493152-23-017322.txt   1114187

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ppcb-20230515.xsd EX-101.SCH 3224
8 XBRL LABEL FILE ppcb-20230515_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE ppcb-20230515_pre.xml EX-101.PRE 22357
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3373
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 330662986 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 23922057
SIC: 2834 Pharmaceutical Preparations